NIH-funded research NIH-funded research

Understanding tuberculosis infection in health workers

Official title: THWART-TB : Testing Health Workers At Risk to advance our understanding of TB infection

Funded at Beth Israel Deaconess Medical Center · NIH-10471574 · Data updated 2026-11-12

This study is looking at how tuberculosis affects health workers in Cape Town, South Africa, by checking their immune responses every three months to help tell the difference between current and past infections, which could lead to better ways to screen for TB in people who are at higher risk.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startFebruary 16, 2023
Project endJanuary 31, 2026
Funding year2023
Award (this year)$1,189,520
NIH project number1DP2AI176896-01
Project IDNIH-10471574 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are health workers in high-risk areas, particularly those in Cape Town, South Africa.

Less likely to help

Patients who are not health workers or those not residing in the study location may not benefit from this research.

What this research studies

This research investigates tuberculosis (TB) infection among health workers in Cape Town, South Africa, who are at high risk for TB. It aims to establish a longitudinal cohort study where participants will undergo regular evaluations every three months using novel assays to assess their immune responses to TB. By analyzing these immune responses, the study seeks to differentiate between active TB infections and past infections that have been cleared, ultimately improving TB screening strategies for health workers.

Why it matters

Potential benefit: If successful, this research could lead to more accurate TB screening methods, helping to prevent the disease in high-risk health workers.

How similar studies have gone: Previous research has shown promise in using novel assays for TB detection, suggesting that this approach could yield significant insights.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Nathavitharana, Ruvandhi — Beth Israel Deaconess Medical Center
  • Study coordinator: Nathavitharana, Ruvandhi

Related research

Other NIH-funded projects on the same topics.

  • SATURN MRI ancillary study: statins after intracerebral hemorrhage and brain MRI markers

    This study looks at what happens to brain MRI markers and health outcomes when people with a specific type of brain bleed continue or stop taking statins.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625633

  • Statin use after brain bleed MRI study in ICH patients (SATURN MRI) Ancillary Study

    This project tests whether continuing or stopping statin therapy after an intracerebral hemorrhage affects brain changes seen on MRI and related health outcomes in people with lobar ICH.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625632

  • Statin use after brain bleed: SATURN MRI ancillary study

    This project tests whether continuing statin medicines after a brain bleed (lobar intracerebral hemorrhage) affects new brain blood vessel findings and long-term health.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625628

  • XenCAT: Single Cell Atlas for Xenopus

    Aims to map gene activity at the single-cell level in Xenopus to help understand how cells develop and how this relates to human disease.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11594482

  • Statin use after lobar intracerebral hemorrhage

    This trial compares continuing versus stopping statins in people who had a lobar intracerebral hemorrhage to see how that affects repeat brain bleeds, strokes, heart attacks, and recovery over two years.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11518526

  • Statin use after lobar brain hemorrhage

    This trial compares stopping versus continuing statin medicine in people who had a lobar brain bleed to learn effects on repeat bleeding and future heart or stroke events.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11518525

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.